Canadian DIN & Molecule SearchMolecules A–ZDrug ShortagesResourcesHealth Canada WeeklyRequest a Quote

CEFUROXIME FOR INJECTION USP DIN 02237731

Status: Cancelled Post Market
Holder: PHARMACEUTICAL PARTNERS OF CANADA INC
Molecule: CEFUROXIME (CEFUROXIME SODIUM)

Health Canada record

Active ingredient(s)CEFUROXIME (CEFUROXIME SODIUM) 750 MG
Dosage formPowder For Solution
RouteIntramuscular; Intravenous
SchedulePRESCRIPTION
ClassHuman
ATCJ01DC02 CEFUROXIME
Original market date21-Oct-1998
Current status date15-Feb-2008
SourceHealth Canada DPD

Establishment licence of the holder

Pharmaceutics International Inc. — licence , not currently licensed, last inspection rating I (2026-02-23).

No Canadian shortage report is currently matched to this DIN.

Other Canadian products containing CEFUROXIME (CEFUROXIME SODIUM)

DINProductCompanyFormStrengthStatus
02241639CEFUROXIME FOR INJECTION, USPFRESENIUS KABI CANADA LTDPowder For SolutionCEFUROXIME (CEFUROXIME SODIUM) 1.5 GMarketed
02241638CEFUROXIME FOR INJECTION, USPFRESENIUS KABI CANADA LTDPowder For SolutionCEFUROXIME (CEFUROXIME SODIUM) 750 MGMarketed
02237732CEFUROXIME FOR INJECTION USPPHARMACEUTICAL PARTNERS OF CANADA INCPowder For SolutionCEFUROXIME (CEFUROXIME SODIUM) 1.5 GCancelled Post Market
02237733CEFUROXIME FOR INJECTION USPPHARMACEUTICAL PARTNERS OF CANADA INCPowder For SolutionCEFUROXIME (CEFUROXIME SODIUM) 7.5 GCancelled Post Market
02422328CEFUROXIME FOR INJECTION, USPHIKMA CANADA LIMITEDPowder For SolutionCEFUROXIME (CEFUROXIME SODIUM) 7.5 GDormant
02241640CEFUROXIME FOR INJECTION, USPFRESENIUS KABI CANADA LTDPowder For SolutionCEFUROXIME (CEFUROXIME SODIUM) 7.5 GCancelled Post Market
02422298CEFUROXIME FOR INJECTION, USPHIKMA CANADA LIMITEDPowder For SolutionCEFUROXIME (CEFUROXIME SODIUM) 750 MGDormant
02422301CEFUROXIME FOR INJECTION, USPHIKMA CANADA LIMITEDPowder For SolutionCEFUROXIME (CEFUROXIME SODIUM) 1.5 GDormant
01927264KEFUROXPHARMACEUTICAL PARTNERS OF CANADA INCPowder For SolutionCEFUROXIME (CEFUROXIME SODIUM) 1.5 GCancelled Post Market
01986082KEFUROXPHARMACEUTICAL PARTNERS OF CANADA INCPowder For SolutionCEFUROXIME (CEFUROXIME SODIUM) 7.5 GCancelled Post Market
01927256KEFUROXPHARMACEUTICAL PARTNERS OF CANADA INCPowder For SolutionCEFUROXIME (CEFUROXIME SODIUM) 750 MGCancelled Post Market
01935828KEFUROX INJ PWS 750MG/ADD-VANTAGE VIALELI LILLY CANADA INCPowder For SolutionCEFUROXIME (CEFUROXIME SODIUM) 750 MGCancelled Post Market
00481890ZINACEF INJ 1.5GM/VIALGLAXO CANADA INCPowder For SolutionCEFUROXIME (CEFUROXIME SODIUM) 1.5 GCancelled Post Market
00890936ZINACEF INJ 7.5GM/VIALGLAXO CANADA INCPowder For SolutionCEFUROXIME (CEFUROXIME SODIUM) 7.5 GCancelled Post Market
00497843ZINACEF INJ 750MG/VIALGLAXO CANADA INCPowder For SolutionCEFUROXIME (CEFUROXIME SODIUM) 750 MGCancelled Post Market

Notices of Compliance

NOCDateSubmissionReason
93782008-02-14Abbreviated New Drug Submission (ANDS)MANUFACTURER NAME CHANGE
83832006-11-06Abbreviated New Drug Submission (ANDS)MANUFACTURER NAME CHANGE
21082001-08-24Abbreviated New Drug Submission (ANDS)MANUFACTURER NAME CHANGE
62952000-08-15Supplement to a New Drug Submission (SNDS)PRODUCT NAME CHANGE FROM STERILE CEFUROXIME SODIUM USP
27861998-04-23Abbreviated New Drug Submission (ANDS)
Request a quote for CEFUROXIME FOR INJECTION USP

How to read a Canadian DIN record